Most cases of breast cancer
are not hereditary.
The majority of breast cancer occurs in women who are over 50, with little to no family history of cancer. Identifying patients who are most at risk for sporadic breast cancer can lead to effective interventions, like risk-reducing medications, and enhanced screening protocols.
GeneType for Breast Cancer evaluates the genomic risk of developing breast cancer for women aged 35 or older who do not have a known pathogenic gene variant. This is the majority of women.